Latest Capital Raises News

Healius Limited has completed the $822 million cash sale of Lumus Imaging to Affinity Equity Partners, setting the stage for a strategic refocus on pathology and a substantial special dividend payout.

HitIQ Limited's trading suspension has been lifted following its announcement of a proposed capital raising, signaling renewed investor interest and potential growth opportunities.

HITIQ Ltd has successfully completed a $680,000 placement and launched a $2.92 million rights issue, positioning the company to fund its strategic shift towards the consumer market and expand its footprint in the US.

Platinum Asset Management has entered preliminary talks with L1 Capital about a potential merger that would combine their funds under management to approximately A$18 billion. L1 Capital has also acquired a significant stake in Platinum, signaling serious intent in this strategic consolidation.

Alice Queen Limited has voluntarily suspended trading of its shares on the ASX as it finalises a proposed capital raising, with an announcement expected by 5 May 2025.

BluGlass has completed a $2.3 million placement and launched a $6 million Share Purchase Plan to fund scaling of its GaN laser production, targeting high-growth sectors including quantum sensing and defense.

Anagenics Limited reported a cash outflow of $424K for Q3 2025 but maintains robust liquidity with $1.48 million in available funding, supported by a mix of secured and unsecured loans.

Sparc Technologies has successfully raised up to A$2.7 million through a share placement and a Share Purchase Plan, positioning the company to accelerate commercialisation of its graphene additive ecosparc and support its green hydrogen pilot projects.

BlinkLab Limited has raised A$7.66 million through a well-supported placement to accelerate FDA regulatory trials for its autism and ADHD diagnostic platforms, leveraging its innovative smartphone-based technology.

AdAlta Limited has announced a renounceable rights issue to raise up to $1.3 million, aiming to accelerate its ‘East to West’ cellular immunotherapy strategy and explore new strategic options.

Southern Cross Gold Consolidated Ltd has successfully arranged a C$143 million private placement, positioning the company to accelerate development of its Sunday Creek Gold-Antimony Project in Victoria, Australia.

Nanoveu Limited has successfully raised $2.3 million through a share placement to accelerate development and commercialization of its cutting-edge semiconductor, 3D visualization, and solar coating technologies.